Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973”. Tillsammans bildar de ett unikt fingeravtryck.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science